Listing on the Canadian Securities Exchange & Delisting NEO Bogota, Colombia--(Newsfile Corp. - December 23, 2021) - Medcolcanna Organics Inc. (NEO: MCCN) ("Medcolcanna", "MCCN" or the "Company"), a Canadian integrated medical cannabis company with operations in Colombia, is pleased to announce that it has received approval to have the common shares of the Company ("Common Shares") listed on the Canadian Securities Exchange (the "CSE"). Consequently, the Company has also submitted a request to the Neo Exchange Inc. (the "NEO") to voluntarily delist the Common Shares from the NEO. The Company will be listing its Common Shares on the Canadian Securities Exchange (the "CSE") commencing at the opening of trading on December 30, 2021. The Common Shares are expected to be delisted from the Neo Exchange Inc. ("NEO") at close of business on December 29, 2021 and will begin trading on the CSE under the symbol "MCCN" at the opening bell on December 30, 2021. No action is required by shareholders in connection with this change of listing. For further information regarding the Company, please visit www.medcolcanna.com.
Company Management is excited with the prospect of listing the Common Shares on the CSE and the opportunities it provides to its investors, as the Company continues the ongoing development of its business operations, including pursuing operations in the United States as integral to its business and the value that it expects to provide to its shareholders. In addition, the Company expects that being listed on a junior stock exchange will help reduce the regulatory compliance costs for the Company and allow it to preserve capital while it continues to undertake its growth process and path towards financial self-sustainability.
ABOUT MEDCOLCANNA
Medcolcanna is a Canadian integrated medical cannabis company, whose fully licensed operations are based in Colombia. Led by a proven and successful management team, Medcolcanna has facilities in optimal growing locations which positions the Company to become a global leader in the medical cannabis market.
Medcolcanna employs state of the art organic agricultural technology and innovative pharmaceutical processes to produce high-quality products. The Company's scalable production model and network of pharmaceutical partnerships globally ensures that they remain at the forefront of the medical cannabis industry.
www.medcolcanna.com
https://www.newsfilecorp.com/release/108469